Healios K.K. (TYO:4593)
Japan · Delayed Price · Currency is JPY 318.00
+28.00 (9.66%)
Oct 6, 2026, 3:30 PM JST
Healios K.K. Market Cap
Healios K.K. has a market cap or net worth of 39.31 billion as of October 5, 2026. Its market cap has decreased by -31.75% in one year.
Market Cap
39.31B
Enterprise Value
32.83B
Revenue
59.00M
Ranking
n/a
PE Ratio
189.89
Stock Price
318.00
ChartMarket Cap Chart
Since June 16, 2015, Healios K.K.'s market cap has decreased from 67.08B to 39.31B, a decrease of -41.40%. That is a compound annual growth rate of -4.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 39.31B | 24.26% |
| Dec 30, 2025 | 31.63B | 98.29% |
| Dec 30, 2024 | 15.95B | 29.70% |
| Dec 29, 2023 | 12.30B | -25.62% |
| Dec 30, 2022 | 16.54B | -76.63% |
| Dec 30, 2021 | 70.75B | -30.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SanBio Company | 78.14B |
| Heartseed | 61.81B |
| Cuorips | 58.43B |
| 3-D Matrix | 53.88B |
| Japan Tissue Engineering | 33.75B |
| Innovacell | 26.19B |
| Stella Pharma | 16.74B |
| RaQualia Pharma | 15.80B |